Harry LeVine

6.9k total citations · 1 hit paper
72 papers, 5.3k citations indexed

About

Harry LeVine is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Harry LeVine has authored 72 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Physiology, 30 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in Harry LeVine's work include Alzheimer's disease research and treatments (57 papers), Cholinesterase and Neurodegenerative Diseases (16 papers) and Computational Drug Discovery Methods (15 papers). Harry LeVine is often cited by papers focused on Alzheimer's disease research and treatments (57 papers), Cholinesterase and Neurodegenerative Diseases (16 papers) and Computational Drug Discovery Methods (15 papers). Harry LeVine collaborates with scholars based in United States, Germany and Sweden. Harry LeVine's co-authors include Lary C. Walker, M. Paul Murphy, Mathias Jucker, Tina L. Beckett, Rebecca F. Rosen, Jeffrey N. Keller, Adam M. Weidner, Ela Patel, Irfan Baig and K. Peter R. Nilsson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Harry LeVine

72 papers receiving 5.2k citations

Hit Papers

Thioflavine T interaction with synthetic Alzheimer's dise... 1993 2026 2004 2015 1993 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry LeVine United States 36 3.3k 2.6k 776 689 670 72 5.3k
Joseph T. Jarrett United States 29 3.0k 0.9× 3.6k 1.4× 556 0.7× 591 0.9× 551 0.8× 47 5.9k
Lars O. Tjernberg Sweden 34 4.3k 1.3× 3.5k 1.3× 1.0k 1.4× 759 1.1× 456 0.7× 107 6.3k
Jan Bieschke United States 32 3.1k 0.9× 3.1k 1.2× 613 0.8× 511 0.7× 528 0.8× 56 6.0k
Michael G. Zagorski United States 36 3.4k 1.0× 3.4k 1.3× 806 1.0× 811 1.2× 279 0.4× 67 6.0k
Saskia Milton United States 21 5.5k 1.7× 4.3k 1.7× 968 1.2× 919 1.3× 699 1.0× 34 7.5k
Leonid Breydo United States 30 2.1k 0.6× 3.0k 1.1× 340 0.4× 342 0.5× 721 1.1× 74 4.8k
Jan Näslund Sweden 30 5.4k 1.7× 3.4k 1.3× 1.4k 1.8× 1.0k 1.5× 680 1.0× 51 7.0k
Christer Nordstedt Sweden 26 3.3k 1.0× 2.7k 1.1× 821 1.1× 700 1.0× 297 0.4× 51 4.7k
Katsuhiko Yanagisawa Japan 51 5.9k 1.8× 4.9k 1.9× 784 1.0× 515 0.7× 907 1.4× 144 9.1k
Gunnar Brinkmalm Sweden 39 3.2k 1.0× 2.2k 0.9× 441 0.6× 341 0.5× 667 1.0× 134 5.4k

Countries citing papers authored by Harry LeVine

Since Specialization
Citations

This map shows the geographic impact of Harry LeVine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry LeVine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry LeVine more than expected).

Fields of papers citing papers by Harry LeVine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry LeVine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry LeVine. The network helps show where Harry LeVine may publish in the future.

Co-authorship network of co-authors of Harry LeVine

This figure shows the co-authorship network connecting the top 25 collaborators of Harry LeVine. A scholar is included among the top collaborators of Harry LeVine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry LeVine. Harry LeVine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meier, Shelby E., Danielle N. Lyons, Jennifer Rodriguez-Rivera, et al.. (2016). Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis. Journal of Neuroscience. 36(3). 1001–1007. 128 indexed citations
2.
Bäck, Marcus, Hanna Appelqvist, Harry LeVine, & K. Peter R. Nilsson. (2016). Anionic Oligothiophenes Compete for Binding of X‐34 but not PIB to Recombinant Aβ Amyloid Fibrils and Alzheimer's Disease Brain‐Derived Aβ. Chemistry - A European Journal. 22(51). 18335–18338. 19 indexed citations
3.
Qosa, Hisham, Harry LeVine, Jeffrey N. Keller, & Amal Kaddoumi. (2014). Mixed oligomers and monomeric amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood–brain barrier model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(9). 1806–1815. 47 indexed citations
4.
Matveev, Sergey V., et al.. (2014). Tritium-labeled (E,E)-2,5-bis(4′-hydroxy-3′-carboxystyryl)benzene as a probe for β-amyloid fibrils. Bioorganic & Medicinal Chemistry Letters. 24(23). 5534–5536. 4 indexed citations
5.
Bag, Seema, Abha Sood, Hyejin Cho, et al.. (2014). Sulfonamides as multifunctional agents for Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 25(3). 626–630. 74 indexed citations
6.
Niedowicz, Dana M., Tina L. Beckett, Sergey V. Matveev, et al.. (2012). Pittsburgh compound B and the postmortem diagnosis of alzheimer disease. Annals of Neurology. 72(4). 564–570. 29 indexed citations
7.
Török, Béla, Abha Sood, Seema Bag, et al.. (2012). Structure–Activity Relationships of Organofluorine Inhibitors of β‐Amyloid Self‐Assembly. ChemMedChem. 7(5). 910–919. 34 indexed citations
8.
Walker, Lary C. & Harry LeVine. (2012). Corruption and Spread of Pathogenic Proteins in Neurodegenerative Diseases. Journal of Biological Chemistry. 287(40). 33109–33115. 57 indexed citations
9.
Rosen, Rebecca F., Jason J. Fritz, Jeromy Dooyema, et al.. (2011). Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic rats. Journal of Neurochemistry. 120(5). 660–666. 99 indexed citations
10.
Cenini, Giovanna, Amy L.S. Dowling, Tina L. Beckett, et al.. (2011). Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(2). 130–138. 101 indexed citations
11.
Weidner, Adam M., Tina L. Beckett, Dana M. Niedowicz, et al.. (2011). RNA Oxidation Adducts 8-OHG and 8-OHA Change with Aβ42 Levels in Late-Stage Alzheimer's Disease. PLoS ONE. 6(9). e24930–e24930. 21 indexed citations
12.
13.
Beckett, Tina L., Dana M. Niedowicz, Christa M. Studzinski, et al.. (2010). Effects of nonsteroidal anti-inflammatory drugs on amyloid-β pathology in mouse skeletal muscle. Neurobiology of Disease. 39(3). 449–456. 20 indexed citations
14.
Abdul, Hafiz Mohmmad, M. Samà, Jennifer L. Furman, et al.. (2009). Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling. Journal of Neuroscience. 29(41). 12957–12969. 265 indexed citations
15.
LeVine, Harry. (2007). Small molecule inhibitors of Abetaassembly. Amyloid. 14(3). 185–197. 53 indexed citations
16.
LeVine, Harry. (2003). Y10W β(1–40) fluorescence reflects epitope exposure in conformers of Alzheimer’s β-peptide. Archives of Biochemistry and Biophysics. 417(1). 112–122. 5 indexed citations
17.
Walker, Lary C. & Harry LeVine. (2000). The cerebral proteopathies. Neurobiology of Aging. 21(4). 559–561. 39 indexed citations
18.
LeVine, Harry. (1997). Stopped-Flow Kinetics Reveal Multiple Phases of Thioflavin T Binding to Alzheimer β(1-40) Amyloid Fibrils. Archives of Biochemistry and Biophysics. 342(2). 306–316. 106 indexed citations
19.
LeVine, Harry. (1995). Soluble multimeric Alzheimer β(1–40) pre-amyloid complexes in dilute solution. Neurobiology of Aging. 16(5). 755–764. 81 indexed citations
20.
Dunea, George, et al.. (1975). Relationship of posture and age to urinary protein excretion.. BMJ. 1(5960). 712–714. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026